Cantor Fitzgerald adjusted its price target for Teradyne stock (NASDAQ:TER), bringing it down to $150 from the previous $160, while still maintaining an Overweight rating on the company's shares.

Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (ACRV) with an Overweight rating without a price target The company has two ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

Howard Lutnick, the wealthy Wall Street executive whom President Trump has tapped to lead the Department of Commerce, ...

Cantor Fitzgerald currently has a “Overweight” rating and a $160.00 price objective on the stock. The consensus estimate for DoorDash’s current full-year earnings is $0.27 per share. Get ...

Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...

Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...

Cantor Fitzgerald has a “Overweight” rating and a $67.00 price objective on the stock. The consensus estimate for Celldex Therapeutics’ current full-year earnings is ($2.48) per share. Get ...